首页 > 最新文献

Tokai Journal of Experimental and Clinical Medicine最新文献

英文 中文
A Boy Presenting with a Fever and Pancytopenia Diagnosed with Systemic Lupus Erythematosus without a Positive Anti-ds-DNA Antibody Result or Hypocomplementemia: A Case Report. 一个男孩表现为发烧和全血细胞减少诊断为系统性红斑狼疮没有阳性抗-ds- dna抗体结果或补体不足:1例报告。
Q3 Medicine Pub Date : 2022-12-20
Yuichi Kama, Kenta Kuruma, Tomofumi Otomo, Takashi Sakama, Kosuke Akiyama, Hiromitsu Takakura, Daisuke Toyama, Kota Hirai, Hiroyuki Mochizuki, Masahiko Kato

Background: Hematological involvement, including anemia, leukopenia, lymphopenia, and thrombocytopenia, is one of the most common manifestations of childhood-onset systemic lupus erythematosus (cSLE). Specifically, relatively severe forms of hematological involvement, such as macrophage activation syndrome (MAS) and thrombotic microangiopathy, occur in the course of the disease. Positivity for anti-double stranded-DNA (ds-DNA) antibody and hypocomplementemia are important as not only criteria of diagnosing cSLE but also in the determination of the disease activity.

Case report: A 13-year-old boy without pre-existing disease was referred to our hospital chiefly complaining of a fever for > 7 days, long-lasting malaise, nausea, and non-malar face rash. His blood examination showed pancytopenia and hyperferritinemia, but positive results for anti-ds-DNA antibody and hypocomplementemia were not recognized. Bone marrow aspiration revealed no evidence of malignant diseases, hemophagocytic lymphohistiocytosis, or MAS. A renal biopsy for the differential diagnosis of proteinuria and hematuria revealed class IIIa +V lupus nephritis, leading to the diagnosis of cSLE.

Conclusions: It is important for cSLE to be considered in patients with pancytopenia, even those without positive anti-ds-DNA antibody findings or hypocomplementemia, and for aggressive approaches to be adopted for the differential diagnosis, including a renal biopsy.

背景:血液学受累,包括贫血、白细胞减少、淋巴细胞减少和血小板减少,是儿童期发病的系统性红斑狼疮(cSLE)最常见的表现之一。具体而言,相对严重的血液学受累形式,如巨噬细胞激活综合征(MAS)和血栓性微血管病,会在疾病过程中发生。抗双链dna (ds-DNA)抗体阳性和低补体血症不仅是诊断cSLE的重要标准,而且是确定疾病活动性的重要标准。病例报告:一名无既往疾病的13岁男孩转介至我院,主诉发热> 7天,长期不适,恶心,非疟疾性面部皮疹。他的血液检查显示全血细胞减少症和高铁蛋白血症,但抗ds- dna抗体和低补体血症阳性结果未被确认。骨髓穿刺未发现恶性疾病、噬血细胞性淋巴组织细胞增多症或MAS。鉴别蛋白尿和血尿的肾活检显示为IIIa +V级狼疮性肾炎,导致cSLE的诊断。结论:在全血细胞减少患者中,即使没有抗ds- dna抗体阳性发现或补体不足,也要考虑cSLE,并采用积极的方法进行鉴别诊断,包括肾活检。
{"title":"A Boy Presenting with a Fever and Pancytopenia Diagnosed with Systemic Lupus Erythematosus without a Positive Anti-ds-DNA Antibody Result or Hypocomplementemia: A Case Report.","authors":"Yuichi Kama,&nbsp;Kenta Kuruma,&nbsp;Tomofumi Otomo,&nbsp;Takashi Sakama,&nbsp;Kosuke Akiyama,&nbsp;Hiromitsu Takakura,&nbsp;Daisuke Toyama,&nbsp;Kota Hirai,&nbsp;Hiroyuki Mochizuki,&nbsp;Masahiko Kato","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Hematological involvement, including anemia, leukopenia, lymphopenia, and thrombocytopenia, is one of the most common manifestations of childhood-onset systemic lupus erythematosus (cSLE). Specifically, relatively severe forms of hematological involvement, such as macrophage activation syndrome (MAS) and thrombotic microangiopathy, occur in the course of the disease. Positivity for anti-double stranded-DNA (ds-DNA) antibody and hypocomplementemia are important as not only criteria of diagnosing cSLE but also in the determination of the disease activity.</p><p><strong>Case report: </strong>A 13-year-old boy without pre-existing disease was referred to our hospital chiefly complaining of a fever for > 7 days, long-lasting malaise, nausea, and non-malar face rash. His blood examination showed pancytopenia and hyperferritinemia, but positive results for anti-ds-DNA antibody and hypocomplementemia were not recognized. Bone marrow aspiration revealed no evidence of malignant diseases, hemophagocytic lymphohistiocytosis, or MAS. A renal biopsy for the differential diagnosis of proteinuria and hematuria revealed class IIIa +V lupus nephritis, leading to the diagnosis of cSLE.</p><p><strong>Conclusions: </strong>It is important for cSLE to be considered in patients with pancytopenia, even those without positive anti-ds-DNA antibody findings or hypocomplementemia, and for aggressive approaches to be adopted for the differential diagnosis, including a renal biopsy.</p>","PeriodicalId":38819,"journal":{"name":"Tokai Journal of Experimental and Clinical Medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40492413","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Pilot Study of Transdermal Application of Diphenhydramine to the Nasal Ala in Patients with Allergic Rhinitis and Asthma. 苯海拉明经皮应用于变应性鼻炎及哮喘患者鼻甲的初步研究。
Q3 Medicine Pub Date : 2022-12-20
Mitsuhiro Kamimura, Toshiya Inui, Atsuto Mouri, Hiroaki Todo, Kenji Sugibayashi, Koichiro Asano

Background: To date, topical allergic rhinitis drugs must be applied intranasally. We studied the efficacy, safety, and impact on co-existing asthma symptoms of transdermal delivery of diphenhydramine through the nasal ala.

Methods: We enrolled outpatients with symptomatic allergic rhinitis and asthma who were on stable medication for at least 4 weeks. Patients applied diphenhydramine ointment, 0.07 g measured with weighing spoon (0.7 mg diphenhydramine), to the nasal ala twice a day for 2 weeks, followed by 2 weeks' washout. Effects were assessed with the Japanese Allergic Rhinitis Standard Quality of Life Questionnaire (JRQLQ) and Self-assessment of Allergic Rhinitis and Asthma (SACRA) and Asthma Control Test (ACT) questionnaires.

Results: Ten patients participated in the study. Two patients experienced acute exacerbation of asthma during the intervention phase, but no other adverse effects occurred. Self-assessments indicated efficacy in treating nasal symptoms in 5 patients. No significant changes in scores were seen, although mean total JRQLQ score showed a numerical improvement (from 34.3 [21.0] to 14.4 [8.8]; P = 0.0547). Asthma symptoms improved subjectively in 2 patients.

Conclusions: The efficacy of transdermal application of diphenhydramine on the nasal ala for treating allergic rhinitis was not conclusive, but appears to be effective in certain patients.

背景:迄今为止,局部变应性鼻炎药物必须应用于鼻内。我们研究了经鼻翼经皮给药苯海拉明的有效性、安全性以及对共存哮喘症状的影响。方法:我们招募了有症状的变应性鼻炎和哮喘的门诊患者,这些患者服用稳定的药物至少4周。患者将0.07 g苯海拉明软膏(苯海拉明0.7 mg)涂抹于鼻侧,每天2次,连续2周,然后冲洗2周。采用日本变应性鼻炎标准生活质量问卷(JRQLQ)、变应性鼻炎和哮喘自评问卷(SACRA)和哮喘控制测试问卷(ACT)评估效果。结果:10例患者参与研究。2例患者在干预期出现哮喘急性加重,但未发生其他不良反应。自评结果显示5例患者鼻部症状得到有效治疗。虽然JRQLQ的平均总得分在数值上有所改善(从34.3[21.0]到14.4[8.8]),但得分没有明显变化;P = 0.0547)。2例患者主观哮喘症状改善。结论:鼻翼经皮应用苯海拉明治疗变应性鼻炎的疗效尚无定论,但对某些患者似乎有效。
{"title":"A Pilot Study of Transdermal Application of Diphenhydramine to the Nasal Ala in Patients with Allergic Rhinitis and Asthma.","authors":"Mitsuhiro Kamimura,&nbsp;Toshiya Inui,&nbsp;Atsuto Mouri,&nbsp;Hiroaki Todo,&nbsp;Kenji Sugibayashi,&nbsp;Koichiro Asano","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>To date, topical allergic rhinitis drugs must be applied intranasally. We studied the efficacy, safety, and impact on co-existing asthma symptoms of transdermal delivery of diphenhydramine through the nasal ala.</p><p><strong>Methods: </strong>We enrolled outpatients with symptomatic allergic rhinitis and asthma who were on stable medication for at least 4 weeks. Patients applied diphenhydramine ointment, 0.07 g measured with weighing spoon (0.7 mg diphenhydramine), to the nasal ala twice a day for 2 weeks, followed by 2 weeks' washout. Effects were assessed with the Japanese Allergic Rhinitis Standard Quality of Life Questionnaire (JRQLQ) and Self-assessment of Allergic Rhinitis and Asthma (SACRA) and Asthma Control Test (ACT) questionnaires.</p><p><strong>Results: </strong>Ten patients participated in the study. Two patients experienced acute exacerbation of asthma during the intervention phase, but no other adverse effects occurred. Self-assessments indicated efficacy in treating nasal symptoms in 5 patients. No significant changes in scores were seen, although mean total JRQLQ score showed a numerical improvement (from 34.3 [21.0] to 14.4 [8.8]; P = 0.0547). Asthma symptoms improved subjectively in 2 patients.</p><p><strong>Conclusions: </strong>The efficacy of transdermal application of diphenhydramine on the nasal ala for treating allergic rhinitis was not conclusive, but appears to be effective in certain patients.</p>","PeriodicalId":38819,"journal":{"name":"Tokai Journal of Experimental and Clinical Medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40492412","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Miscarriage in a patient with Glanzmann Thrombasthenia and low ovarian reserve: A case report 格兰兹曼血栓性贫血合并卵巢储备不足患者流产1例
Q3 Medicine Pub Date : 2022-10-29 DOI: 10.52142/omujecm.39.4.62
I. E. Uluisik, M. Sonkaya, N. Dokuzeylul Gungor
Glanzmann thrombasthenia (GT), which has an autosomal inheritance pattern, is a hemorrhagic disorder mostly complicated by mucocutaneous bleeding. The severity of this bleeding disorder varies from mild bruising to frequent severe bleeding. Prepartum, peripartum and postpartum bleeding risks are increased in these patients. In addition to the hemorrhagic complications that endanger maternal and fetal well-being, the risk of miscarriage is increased due to maternal antibodies to the platelets found on conceptus-derived trophoblast (placental) cells. In this case report, we report a patient who had a miscarriage in 7+1 week. Our patient had GT, low ovarian reserve, HPV positivity, bilateral dermoid cyst and was complicated by infertility.
Glanzmann血栓减少症(GT)是一种常染色体遗传型的出血性疾病,多并发皮肤粘膜出血。这种出血性疾病的严重程度从轻微的瘀伤到频繁的严重出血不等。这些患者的产前、围生期和产后出血风险增加。除了危及母体和胎儿健康的出血性并发症外,由于母体在母体滋养细胞(胎盘)细胞中发现的血小板抗体,流产的风险也会增加。在本病例报告中,我们报告了一例在7+1周内流产的患者。我们的患者有GT,卵巢储备不足,HPV阳性,双侧皮样囊肿并合并不孕症。
{"title":"Miscarriage in a patient with Glanzmann Thrombasthenia and low ovarian reserve: A case report","authors":"I. E. Uluisik, M. Sonkaya, N. Dokuzeylul Gungor","doi":"10.52142/omujecm.39.4.62","DOIUrl":"https://doi.org/10.52142/omujecm.39.4.62","url":null,"abstract":"Glanzmann thrombasthenia (GT), which has an autosomal inheritance pattern, is a hemorrhagic disorder mostly complicated by mucocutaneous bleeding. The severity of this bleeding disorder varies from mild bruising to frequent severe bleeding. Prepartum, peripartum and postpartum bleeding risks are increased in these patients. In addition to the hemorrhagic complications that endanger maternal and fetal well-being, the risk of miscarriage is increased due to maternal antibodies to the platelets found on conceptus-derived trophoblast (placental) cells. In this case report, we report a patient who had a miscarriage in 7+1 week. Our patient had GT, low ovarian reserve, HPV positivity, bilateral dermoid cyst and was complicated by infertility.","PeriodicalId":38819,"journal":{"name":"Tokai Journal of Experimental and Clinical Medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78051961","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The effects of sperm parameters and sperm DNA damage on pregnancy outcomes of women undergoing intrauterine insemination 精子参数和精子DNA损伤对宫内授精妇女妊娠结局的影响
Q3 Medicine Pub Date : 2022-10-29 DOI: 10.52142/omujecm.39.4.12
Murat Önal, M. Kavrut, N. Dokuzeylül Güngör, T. Gürbüz
{"title":"The effects of sperm parameters and sperm DNA damage on pregnancy outcomes of women undergoing intrauterine insemination","authors":"Murat Önal, M. Kavrut, N. Dokuzeylül Güngör, T. Gürbüz","doi":"10.52142/omujecm.39.4.12","DOIUrl":"https://doi.org/10.52142/omujecm.39.4.12","url":null,"abstract":"","PeriodicalId":38819,"journal":{"name":"Tokai Journal of Experimental and Clinical Medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81854426","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An evaluation of IGF-1 and IGFBP-3 levels in patients receiving growth hormone therapy and these parameters therapeutic efficacy 接受生长激素治疗的患者IGF-1和IGFBP-3水平的评估及这些参数的治疗效果
Q3 Medicine Pub Date : 2022-10-29 DOI: 10.52142/omujecm.39.4.51
A. Asik, S. Bolu
{"title":"An evaluation of IGF-1 and IGFBP-3 levels in patients receiving growth hormone therapy and these parameters therapeutic efficacy","authors":"A. Asik, S. Bolu","doi":"10.52142/omujecm.39.4.51","DOIUrl":"https://doi.org/10.52142/omujecm.39.4.51","url":null,"abstract":"","PeriodicalId":38819,"journal":{"name":"Tokai Journal of Experimental and Clinical Medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79507202","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Values of intensive care scores in predicting morbidity and mortality in patients treated for COVID-19 pneumonia 重症监护评分在预测COVID-19肺炎患者发病率和死亡率中的价值
Q3 Medicine Pub Date : 2022-10-29 DOI: 10.52142/omujecm.39.4.43
Hale Kefeli Çelik, Z. Doğanay, Ramazan BURAK FERLİ
Some of the patients with COVID-19 pneumonia are followed up in intensive care units (ICU). This study aimed to determine the success of intensive care scores used in patients followed up in the ICU with the diagnosis of COVID-19 pneumonia in predicting morbidity and mortality. This retrospective study included patients treated for COVID-19 pneumonia in the ICUs of Samsun Training and Research Hospital. We used the patients' demographic characteristics, vital signs, arterial blood gas values, radiological imaging, and laboratory data by using the hospital database and patient files. Group I was composed of alive patients, while Group II was of dead ones. A total of 75 patients were included in the study, of which 34 (45.3%) were female and 41 (54.7%) were male. The median length of intensive care stay was 8 (5-15) days in Group I patients and 5 (2-8) days in Group II patients, which was higher in alive patients (p=0.004). Radiological involvement was present in 93.3% (n=70) of the patients, and involvement was observed in both lungs in 77.3% (n=58). We observed complications in 54.7% (n=41) of the patients, whereas the incidence of complications was 20% in Group I and 72% in Group II, which was statistically significant (p<0.001). APACHE II, PSI, SOFA, qSOFA, SMART-COP, CURB65, A-DROP and NEWS2 scores were statistically significantly higher in patients who died, whereas APACHE II, SOFA, qSOFA, and SMART-COP scores were more successful in predicting morbidity. It is vital to predict the mortality risk early in patients with COVID-19 pneumonia followed up in intensive care units. Among the scoring systems, APACHE II, PSI, SOFA, qSOFA, SMART-COP, CURB65, A-DROP, and NEWS2 can be used safely to predict mortality. Copyright © 2022 Ondokuz Mayis Universitesi. All rights reserved.
部分COVID-19肺炎患者在重症监护病房(ICU)接受随访。本研究旨在确定重症监护评分在预测COVID-19肺炎在ICU随访患者的发病率和死亡率方面的成功。本回顾性研究纳入了在三星培训研究医院重症监护室治疗的COVID-19肺炎患者。通过医院数据库和患者档案,我们使用了患者的人口统计学特征、生命体征、动脉血气值、放射成像和实验室数据。第一组为在世患者,第二组为死亡患者。共纳入75例患者,其中女性34例(45.3%),男性41例(54.7%)。重症监护时间中位数I组为8(5-15)天,II组为5(2-8)天,在世患者中位数更高(p=0.004)。93.3% (n=70)的患者表现为影像学受累,77.3% (n=58)的患者表现为双肺受累。我们观察到54.7% (n=41)的患者出现并发症,而I组的并发症发生率为20%,II组为72%,差异有统计学意义(p<0.001)。APACHE II、PSI、SOFA、qSOFA、SMART-COP、CURB65、A-DROP和NEWS2评分在死亡患者中有统计学意义上较高,而APACHE II、SOFA、qSOFA和SMART-COP评分在预测发病率方面更成功。对重症监护病房随访的COVID-19肺炎患者进行早期死亡风险预测至关重要。在评分系统中,APACHE II、PSI、SOFA、qSOFA、SMART-COP、CURB65、A-DROP、NEWS2可安全用于预测死亡率。版权所有©2022 Ondokuz Mayis Universitesi。版权所有。
{"title":"Values of intensive care scores in predicting morbidity and mortality in patients treated for COVID-19 pneumonia","authors":"Hale Kefeli Çelik, Z. Doğanay, Ramazan BURAK FERLİ","doi":"10.52142/omujecm.39.4.43","DOIUrl":"https://doi.org/10.52142/omujecm.39.4.43","url":null,"abstract":"Some of the patients with COVID-19 pneumonia are followed up in intensive care units (ICU). This study aimed to determine the success of intensive care scores used in patients followed up in the ICU with the diagnosis of COVID-19 pneumonia in predicting morbidity and mortality. This retrospective study included patients treated for COVID-19 pneumonia in the ICUs of Samsun Training and Research Hospital. We used the patients' demographic characteristics, vital signs, arterial blood gas values, radiological imaging, and laboratory data by using the hospital database and patient files. Group I was composed of alive patients, while Group II was of dead ones. A total of 75 patients were included in the study, of which 34 (45.3%) were female and 41 (54.7%) were male. The median length of intensive care stay was 8 (5-15) days in Group I patients and 5 (2-8) days in Group II patients, which was higher in alive patients (p=0.004). Radiological involvement was present in 93.3% (n=70) of the patients, and involvement was observed in both lungs in 77.3% (n=58). We observed complications in 54.7% (n=41) of the patients, whereas the incidence of complications was 20% in Group I and 72% in Group II, which was statistically significant (p<0.001). APACHE II, PSI, SOFA, qSOFA, SMART-COP, CURB65, A-DROP and NEWS2 scores were statistically significantly higher in patients who died, whereas APACHE II, SOFA, qSOFA, and SMART-COP scores were more successful in predicting morbidity. It is vital to predict the mortality risk early in patients with COVID-19 pneumonia followed up in intensive care units. Among the scoring systems, APACHE II, PSI, SOFA, qSOFA, SMART-COP, CURB65, A-DROP, and NEWS2 can be used safely to predict mortality. Copyright © 2022 Ondokuz Mayis Universitesi. All rights reserved.","PeriodicalId":38819,"journal":{"name":"Tokai Journal of Experimental and Clinical Medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82124897","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The relationship between demographic indicators and mortality rate of COVID-19 disease comparatively and retrospectively in different waves of COVID-19 disease in Iran 伊朗不同流行阶段人口统计学指标与COVID-19死亡率的对比与回顾性分析
Q3 Medicine Pub Date : 2022-10-29 DOI: 10.52142/omujecm.39.4.22
K. Aghakhani, S. Soltani, A. Memarian, S. Mehrpisheh
Coronavirus disease-19 (COVID-19) is a novel emerging infectious disease caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARSCoV-2). In this study, we aimed to examine the relationship between demographic indicators and mortality rates in Covid-19 disease in different Covid-19 waves in Iran. In this retrospective cross-sectional study, the study population consisted of 9874 patients of Covid-19 admitted to Hazrat Rasoul Akram Hospital of Tehran, from the beginning of the disease to the end of the fifth wave. Demographic variables such as age and sex as well as clinical variables such as hospitalization date and mortality rate were collected and evaluated. The analysis was performed using SPSS software version 26. The mean age of 9874 participants was 58.9 +/- 17.0 years. In this study 5510 (55.8%) of patients were male. 1762 (17.8%) patients died. The fifth wave had the highest number of patients (31.1%) and the trend in the number of patients was increasing from wave second to fifth. However, the percentage of death was lower in waves fourth (14.5%) and fifth (15.3%). The mean age of deceased patients was significantly greater than alive patients (69.25 +/- 14.60 vs. 56.76 +/- 16.75, P=0.0001). The frequency of male deaths was significantly higher than female deaths (P=0.0001). The results of the present study indicate that the frequency of mortality in recent waves, despite a significant increase in hospitalization, has been decreased. It can also be said that mortality increases with age as well as male gender, and males are more prone to death due to covid-19 disease with age. Copyright © 2022 Ondokuz Mayis Universitesi. All rights reserved.
冠状病毒病-19 (COVID-19)是由严重急性呼吸综合征冠状病毒2型(SARSCoV-2)引起的一种新型传染病。在这项研究中,我们旨在研究伊朗不同Covid-19浪潮中人口统计学指标与Covid-19疾病死亡率之间的关系。在这项回顾性横断面研究中,研究人群包括9874名从疾病开始到第五波结束入住德黑兰Hazrat Rasoul Akram医院的Covid-19患者。收集和评估了年龄和性别等人口统计变量以及住院日期和死亡率等临床变量。采用SPSS软件26版进行分析。9874名参与者的平均年龄为58.9±17.0岁。本研究中5510例(55.8%)患者为男性。死亡1762例(17.8%)。第五波患者人数最多(31.1%),从第二波到第五波患者人数呈增加趋势。然而,第四波(14.5%)和第五波(15.3%)的死亡率较低。死亡患者的平均年龄明显大于存活患者(69.25 +/- 14.60 vs. 56.76 +/- 16.75, P=0.0001)。男性死亡率显著高于女性死亡率(P=0.0001)。本研究的结果表明,尽管住院人数大幅增加,但最近几波的死亡率有所下降。也可以说,死亡率随年龄和男性性别的增加而增加,随着年龄的增长,男性更容易因covid-19疾病而死亡。版权所有©2022 Ondokuz Mayis Universitesi。版权所有。
{"title":"The relationship between demographic indicators and mortality rate of COVID-19 disease comparatively and retrospectively in different waves of COVID-19 disease in Iran","authors":"K. Aghakhani, S. Soltani, A. Memarian, S. Mehrpisheh","doi":"10.52142/omujecm.39.4.22","DOIUrl":"https://doi.org/10.52142/omujecm.39.4.22","url":null,"abstract":"Coronavirus disease-19 (COVID-19) is a novel emerging infectious disease caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARSCoV-2). In this study, we aimed to examine the relationship between demographic indicators and mortality rates in Covid-19 disease in different Covid-19 waves in Iran. In this retrospective cross-sectional study, the study population consisted of 9874 patients of Covid-19 admitted to Hazrat Rasoul Akram Hospital of Tehran, from the beginning of the disease to the end of the fifth wave. Demographic variables such as age and sex as well as clinical variables such as hospitalization date and mortality rate were collected and evaluated. The analysis was performed using SPSS software version 26. The mean age of 9874 participants was 58.9 +/- 17.0 years. In this study 5510 (55.8%) of patients were male. 1762 (17.8%) patients died. The fifth wave had the highest number of patients (31.1%) and the trend in the number of patients was increasing from wave second to fifth. However, the percentage of death was lower in waves fourth (14.5%) and fifth (15.3%). The mean age of deceased patients was significantly greater than alive patients (69.25 +/- 14.60 vs. 56.76 +/- 16.75, P=0.0001). The frequency of male deaths was significantly higher than female deaths (P=0.0001). The results of the present study indicate that the frequency of mortality in recent waves, despite a significant increase in hospitalization, has been decreased. It can also be said that mortality increases with age as well as male gender, and males are more prone to death due to covid-19 disease with age. Copyright © 2022 Ondokuz Mayis Universitesi. All rights reserved.","PeriodicalId":38819,"journal":{"name":"Tokai Journal of Experimental and Clinical Medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86463604","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Change in GFR in relation to pulse rate, dipping blood pressure, anti-hypertensives, NLR and PLR in patients with chronic kidney disease 慢性肾病患者GFR与脉率、低血压、抗高血压、NLR和PLR相关的变化
Q3 Medicine Pub Date : 2022-10-29 DOI: 10.52142/omujecm.39.4.3
Hüseyin Duru
{"title":"Change in GFR in relation to pulse rate, dipping blood pressure, anti-hypertensives, NLR and PLR in patients with chronic kidney disease","authors":"Hüseyin Duru","doi":"10.52142/omujecm.39.4.3","DOIUrl":"https://doi.org/10.52142/omujecm.39.4.3","url":null,"abstract":"","PeriodicalId":38819,"journal":{"name":"Tokai Journal of Experimental and Clinical Medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86477514","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Significance of tissue oxygenation in patients connected to a mechanical ventilator 连接机械呼吸机患者组织氧合的意义
Q3 Medicine Pub Date : 2022-10-29 DOI: 10.52142/omujecm.39.4.44
Fulya Köse, Bülent Güngörer, H. Arslan, A. S. Girişgin, Z. D. Dündar, Merve Güven
{"title":"Significance of tissue oxygenation in patients connected to a mechanical ventilator","authors":"Fulya Köse, Bülent Güngörer, H. Arslan, A. S. Girişgin, Z. D. Dündar, Merve Güven","doi":"10.52142/omujecm.39.4.44","DOIUrl":"https://doi.org/10.52142/omujecm.39.4.44","url":null,"abstract":"","PeriodicalId":38819,"journal":{"name":"Tokai Journal of Experimental and Clinical Medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84704219","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Management of subcutaneous emphysema due to penetrating oropharyngeal trauma 穿透性口咽外伤所致皮下肺气肿的处理
Q3 Medicine Pub Date : 2022-10-29 DOI: 10.52142/omujecm.39.4.64
Emre Demirel, E. Tahir, H. Albayrak, N. Yener, S. Atmaca
the event of upper airway edema. A previously undetected subcutaneous emphysema in the patient’s submandibular region and anterior thoracic wall was found. We used a syringe to drain subcutaneous emphysema. In the presence of imminent respiratory failure, we performed elective endotracheal intubation using direct laryngoscopy without incident. The child was transported to the pediatric intensive care unit and placed on mechanical ventilation. On the first day of his hospitalization, he had a fever
上呼吸道水肿的事件。在患者的下颌下区域和前胸壁发现了以前未发现的皮下肺气肿。我们用注射器引流皮下肺气肿。在即将出现呼吸衰竭的情况下,我们使用直接喉镜进行了选择性气管内插管,没有发生任何事故。这名儿童被送往儿科重症监护病房,并接受了机械通气。住院的第一天,他就发烧了
{"title":"Management of subcutaneous emphysema due to penetrating oropharyngeal trauma","authors":"Emre Demirel, E. Tahir, H. Albayrak, N. Yener, S. Atmaca","doi":"10.52142/omujecm.39.4.64","DOIUrl":"https://doi.org/10.52142/omujecm.39.4.64","url":null,"abstract":"the event of upper airway edema. A previously undetected subcutaneous emphysema in the patient’s submandibular region and anterior thoracic wall was found. We used a syringe to drain subcutaneous emphysema. In the presence of imminent respiratory failure, we performed elective endotracheal intubation using direct laryngoscopy without incident. The child was transported to the pediatric intensive care unit and placed on mechanical ventilation. On the first day of his hospitalization, he had a fever","PeriodicalId":38819,"journal":{"name":"Tokai Journal of Experimental and Clinical Medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90431115","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Tokai Journal of Experimental and Clinical Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1